<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Live, attenuated replication competent RVFV vaccines in use or in development.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Vaccine</th>
    <th>Derivation/Basis for attenuation</th>
    <th>Marketing/Usage</th>
    <th>Target indication</th>
    <th>Adverse effects and other potential concerns</th>
    <th>Evaluated for human use</th>
    <th>Characteristics reducing risk of reassortment</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Smithburn Neurotropic Strain (SNS)</td>
    <td>Derived by empirical passage/ Not defined</td>
    <td>Onderstepoort Biological Products (OBP) and (intermittently) other manufacturers (Egypt, Kenya)/50 years use in parts of Africa</td>
    <td>Adult, (non-pregnant) ruminants</td>
    <td>
     <list list-type="simple" id="l0005">
      <list-item id="o0005">
       <label>1.</label>
       <p id="p0005">Low rates of abortions in sheep</p>
      </list-item>
      <list-item id="o0010">
       <label>2.</label>
       <p id="p0010">inconsistent availability, vaccine quality and stability</p>
      </list-item>
     </list>
    </td>
    <td>No</td>
    <td/>
   </tr>
   <tr>
    <td>Clone-13</td>
    <td>Derived by empirical passage/ Internal deletion of 569 nucleotides in NSs</td>
    <td>OBP/Africa since 2010</td>
    <td>Ruminants</td>
    <td>
     <list list-type="simple" id="l0010">
      <list-item id="o0015">
       <label>1.</label>
       <p id="p0015">Single report of fetal malformations and stillbirths (experimental study only)</p>
      </list-item>
      <list-item id="o0020">
       <label>2.</label>
       <p id="p0020">Experimental infection of mosquitoes</p>
      </list-item>
     </list>
    </td>
    <td>No</td>
    <td>No detectable viremia (ruminants) below threshold for mosquito infection</td>
   </tr>
   <tr>
    <td>MP-12</td>
    <td>Derived by passage with chemical mutagenesis/ Multiple attenuating mutations in all 3 segments.</td>
    <td>Zoetis/Conditionally licensed for use in U.S.</td>
    <td>Ruminants, humans</td>
    <td>
     <list list-type="simple" id="l0015">
      <list-item id="o0025">
       <label>1.</label>
       <p id="p0025">Single report of abortion in sheep (experimental study)</p>
      </list-item>
      <list-item id="o0030">
       <label>2.</label>
       <p id="p0030">Experimental transmission to mosquitoes</p>
      </list-item>
     </list>
    </td>
    <td>Phase I-II trials with promising results</td>
    <td>Low viremia in ruminants and humans, below threshold for mosquito infection</td>
   </tr>
   <tr>
    <td>MP-12-NSm-del</td>
    <td>Derived by reverse genetics/ Deletion of NSm plus MP-12 attenuating mutations.</td>
    <td>M.C.I Santé Animale/in development</td>
    <td>Ruminants</td>
    <td>None reported</td>
    <td>No</td>
    <td>No detectable viremia in ruminants. Not infectious for mosquitoes.</td>
   </tr>
   <tr>
    <td>ΔNSs-ΔNSm rRVFV (DDVax™)</td>
    <td>Derived by reverse genetics. Deletion of NSs and NSm</td>
    <td>In development</td>
    <td>Humans, ruminants</td>
    <td>None reported</td>
    <td>In development</td>
    <td>No detectable viremia in ruminants. Not infectious for mosquitoes.</td>
   </tr>
   <tr>
    <td>RVFV-4s</td>
    <td>Derived by reverse genetics/ Split M segment, 4 segments, NSs deletion.</td>
    <td>In development</td>
    <td>Humans, Ruminants</td>
    <td>None reported</td>
    <td>In development</td>
    <td>No detectable viremia in ruminants.</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
